Patient | Sex | Age (years) | Atrophy grade (Marsh criteria) | AAEM | AATG | HLA-DQB1 | HLA-DRB1 |
Coeliac 1 | Male | 6 | III b | + | 252 | 0201–0202 | 3–7 |
Coeliac 2 | Female | 3 | III a | + | 20 | 0201–0202 | 3–7 |
Coeliac 3 | Male | 13 | III b | – | 2 | 0202–0301 | 7–11 |
Coeliac 4 | Female | 5 | III b | + | 102 | 0201–0604 | 3–11 |
Coeliac 5 | Female | 9 | III b | + | 139 | 0201–0202 | 3–7 |
Coeliac 6 | Female | 2 | III b | + | 15 | 0302–0301 | 4–4 |
Coeliac 7 | Female | 4 | III b | + | 28 | 0201–0501 | 1–3 |
Coeliac 8 | Female | 7 | II | + | 111 | 0201–0202 | 3–7 |
Coeliac 9 | Male | 10 | III b | + | 165 | 0202–0301 | 7–11 |
Coeliac 10 | Male | 5 | III b | + | 118 | 0201–0202 | 3–7 |
AAEM, antiendomysial antibody; AATG, antitransglutaminase antibody, expressed as U/ml; HLA, human leucocyte antigen.